Michel Aubanel | Molecular Mechanisms Signaling | Research Excellence Award

Published on by Cell Biologist

Mr. Michel Aubanel | Molecular Mechanisms Signaling | Research Excellence Award

Kerry | France

Michel Aubanel is a senior R&D and innovation leader with more than three decades of experience in the flavors, ingredients, and aroma chemicals industry. He has held global leadership roles across major multinational organizations, driving process development, natural extract innovation, flavor optimization, and analytical research. His expertise spans natural and nature-identical molecules, botanical extracts, taste technologies, and advanced flavor delivery systems, with strong involvement in intellectual property creation and patent development. He has led multidisciplinary teams across Europe and the United States and supported global technology deployment across Asia, Africa, and emerging markets, particularly for alcoholic beverages. A recognized contributor to the scientific community, he serves on international science and flavor boards and is an active member of multiple professional chemical societies. His work is reflected in peer-reviewed toxicological publications and granted patents, highlighting a strong commitment to safety, innovation, and sustainable flavor solutions.

Citation Metrics (Scopus)

100
75
50
25
10
0

Citations
59

Documents
7

h-index
3

Citations

Documents

h-index

Featured Publication

Meenakshi | Signal Transduction Networks | Research Excellence Award

Published on by Cell Biologist

Assoc. Prof. Dr. Meenakshi | Signal Transduction Networks | Research Excellence Award

Chandigarh University | India

Dr. Meenakshi Munjal is an active researcher in the field of wireless communication, contributing extensively to advancements in emerging communication technologies. Over the past several years, she has maintained a strong research trajectory, completing one funded research project and producing a substantial body of scholarly work. Her research output includes more than 30 Scopus-indexed publications and a total citation count of 100, reflecting the growing impact of her contributions within the scientific community. She has authored one book with an ISBN and has two patents published or under process, demonstrating her commitment to innovation and applied research in communication systems. In addition to her publications, she has published eight peer-reviewed journal articles across SCI and Scopus-indexed platforms, strengthening the scientific understanding of wireless networks, signal processing, and communication technologies. Her work aligns with contemporary challenges in wireless systems, contributing to enhanced network performance, reliability, and efficiency. She also holds three professional memberships, supporting collaborative engagement within the research ecosystem. Overall, her research contributions highlight a sustained focus on innovation, scholarly excellence, and the advancement of wireless communication technologies

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

Munjal, M., & Singh, N. P. (2018). Utility aware network selection in small cell. Wireless Networks, 1–14.

Munjal, M., & Singh, N. P. (2019). Group mobility by cooperative communication for high speed railway. Wireless Networks, 25(7), 3857–3866.

Gupta, S. (2014). A review and comprehensive comparison of image denoising techniques. Proceedings of the International Conference on Computing for Sustainable Global Development, 1–6.

Munjal, M., & Singh, N. P. (2019). QoS and cost-aware protocol selection for next generation wireless network. Journal of Network and Systems Management, 27(2), 327–350.

Munjal, M., & Singh, N. P. (2017). Improved network selection for multimedia applications. Transactions on Emerging Telecommunications Technologies, 28(5), e3121.

Munjal, M., & Singh, N. P. (2016). A comparative study of cooperative and non-cooperative game theory in network selection. Computational Techniques in Information and Communication Technologies Conference Proceedings, 1–5.

Meenakshi, G., & Gupta, S. (2014). Advanced level cyclic gray codes with application. International Journal of Electronics Communication and Computer Technology, 1–6.

Munjal, M., & Singh, N. P. (2020). Low cost communication for high speed railway. Wireless Personal Communications, 111(1), 163–178.

Munjal, M. (2024). A comprehensive review of wireless body area network in medical applications. AIP Conference Proceedings, 3100(1), 040013.

Munjal, M., & Dev, S. (2021). Utility based handoff decision for Internet of Everything (IoE). Photonics & Electromagnetics Research Symposium (PIERS) Proceedings, 1396–1405.

Singh, I., & Munjal, M. (2025). Intelligent network selection mechanisms in the Internet of Everything system. IEEE Access.

Munjal, M., Kaistha, K., Gupta, P., Sardana, L., Verma, R., & Verma, S. (2024). Handoff management using RSS in a heterogeneous system. AIP Conference Proceedings, 3072(1), 030003.

Junning Ma | Cell Surface Receptors | Best Research Article Award

Published on by Cell Biologist

Dr. Junning Ma | Cell Surface Receptors | Best Research Article Award

Zhejiang University | China

Dr. Junning Ma has developed a multidisciplinary portfolio spanning neurosurgery, neural engineering, biomaterials, and nanomedicine. Their work integrates neural stem cell biology, targeted drug delivery, and tumor microenvironment modulation to create innovative therapeutic strategies for brain diseases. They have conducted advanced postdoctoral and doctoral research at major institutions, contributing to National Natural Science Foundation of China (NSFC) Youth Fund projects and multiple US-funded NIH and AHA grants. Their research focuses on biomimetic nanocarriers, including cell membrane-coated nanoparticles, PLGA-based delivery systems, and fusion-membrane technologies designed for precision therapy of glioma, pituitary adenoma, and ischemic stroke.

Key projects include engineered neural stem cell membrane-coated nanoparticles for stroke targeting, biomimetic nanoplatforms for cancer immunotherapy, and tumor microenvironment–responsive delivery systems. They have also contributed to studies on neuromodulation, neurotrophic factor-based therapy, neural stem cell transplantation, and photothrombotic stroke models. Their publication record includes high-impact journals such as Materials Today Bio, Biomaterials, Nano Letters, Small, and Cell Reports Physical Science, covering topics like vascular-targeting nanoclusters, polyphenol nanoparticles, and membrane-engineered carriers.

Overall, their research advances translational nanomedicine and regenerative neuroscience, with an emphasis on targeted therapies capable of overcoming the challenges of brain tumor heterogeneity, the blood–brain barrier, and ischemic neural injury.

Profiles: Scopus | Orcid

Featured Publications: 

Ma, J., Win, Y., Xiaojian, Z., et al. (2023). Enhanced EPR effects by folliculostellate cell membrane–coated nanoparticles on invasive pituitary adenoma. Materials Today Bio.

Ma, J., Dai, L., Jianbo, Y., et al. (2023). Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials.

Ma, J., Liu, F., Wendy, C., et al. (2020). Co-presentation of tumor antigens with costimulation via biomimetic nanoparticles for effective cancer immunotherapy. Nano Letters.

Ma, J., Zhang, S., Jun, L., et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membranes of engineered neural stem cells. Small.

Zhihua Wu | Allergen | Best Researcher Award

Published on by Cell Biologist

Mr. Zhihua Wu | Allergen | Best Researcher Award

Nanchnag University | China

Dr. Zhihua Wu is a leading researcher in the field of food science and nanobiotechnology, with a focus on food protein processing, allergen characterization, and functional food development. His work explores the structural and immunological properties of food allergens, particularly those derived from peanuts, soybeans, and almonds, aiming to elucidate mechanisms underlying allergenicity and cross-reactivity. He employs advanced analytical tools such as mass spectrometry, metabolomics, and molecular modeling to investigate how food processing, polyphenol interactions, and roasting alter protein structures and immune responses. Dr. Wu’s recent studies have provided key insights into epitope localization and allergen modification for risk reduction in plant-based foods. His ongoing research projects, funded by major Chinese national programs, include developing safety evaluation and risk mitigation techniques for plant-derived food resources and mapping IgE-binding epitopes of 2S albumins. He also contributes to the understanding of food flavor chemistry, especially changes in tea aroma compounds during processing and storage. Recognized through multiple provincial and national science awards, Dr. Wu’s research advances the interface of food safety, protein chemistry, and functional nutrition, offering innovative strategies for producing hypoallergenic and health-promoting food products.

Profile: Scopus

Featured Publications:

Wu, Z., Gao, K., Geng, Q., Hu, C., Zhang, W., Li, X., Tong, P., Yang, A., & Chen, H. (2025). Impact of the polyphenol structure on the allergenic potential of the peanut allergen Ara h 2. Journal of Agricultural and Food Chemistry, 73(28), 17967–17979.

Hu, C., Luo, Q., Zhou, L., Zhu, W., Gao, K., Geng, Q., Li, X., Yang, A., Tong, P., Wu, Z., & Chen, H. (2025). Purification of Pru du 6 from almond and its cross-reactivity with Gly m 6 from soybean. International Journal of Molecular Sciences, 26(11), 5425.

Zhang, Y., Zhang, J., Li, X., Yang, A., Tong, P., Wu, Z., & Chen, H. (2025). Untargeted metabolomics reveals changes in serum metabolism in peanut-allergic mice treated by raw and roasted peanuts. Food Science and Human Wellness.

Zhou, W., Geng, Q., Zhang, Y., Zhou, X., Wu, Z., Chen, H., & El-Sohaimy, S. (2024). The flavonoid-allergen interaction and its influence on allergenicity. Food Bioscience, 61, 104939. h

Zhang, Y., Geng, Q., Song, M., Li, X., Yang, A., Tong, P., Wu, Z., & Chen, H. (2024). The structure and potential allergenicity of peanut allergen monomers after roasting. Food & Function, 15, 2577–2586.

ALINE TAKEJIMA | Tissue engineering | Women Researcher Award

Published on by Cell Biologist

Dr. ALINE TAKEJIMA | tissue engineering | Women Researcher Award

Dr. ALINE TAKEJIMA, pontificia universidade catolica do parana, Brazil

Dr. Aline Luri Takejima is a physician-scientist from Brazil, specializing in regenerative medicine and wound healing. She holds an MD and a PhD in Health Sciences from the Pontifical Catholic University of Paraná (PUCPR), where she currently conducts postdoctoral research. With a focus on biological therapies involving the amniotic membrane, Wharton’s jelly, and mononuclear stem cells, Dr. Takejima has published in multiple high-impact scientific journals. Her research aims to develop novel regenerative strategies to treat complex wounds and enhance tissue repair. As an active member of PUCPR’s Wound Healing Research Group and the Brazilian Society of Plastic Surgery, she combines scientific rigor with clinical insight to bridge bench-to-bedside innovation. Her academic contributions are guided by a translational approach, offering promising avenues for future clinical applications in tissue engineering.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Focused Research Excellence:
    Dr. Takejima’s work on biological scaffolds and stem cells in wound healing is both innovative and clinically relevant. Her studies using amniotic membrane, Wharton’s jelly, and bone marrow mononuclear cells show promising regenerative outcomes in preclinical models.

  2. Research Productivity:
    With 9 peer-reviewed journal articles in high-quality platforms (e.g., Biomedicines, Tissue Barriers, Annals of Biomedical Engineering), she demonstrates consistent academic output in her field.

  3. Translational Impact:
    Her research bridges basic science and clinical practice, aiming to provide regenerative solutions for patients with chronic wounds and cardiac damage.

  4. Collaborative Engagement:
    Active participation in a multidisciplinary wound healing research group, contributing to cross-functional scientific advancements.

  5. Recognition Potential:
    As a young, emerging woman researcher in biomedical sciences, she stands as a role model for future female scientists in Latin America and beyond.

🔧 Areas for Improvement:

  1. Intellectual Property & Innovation:
    No patents filed yet; transitioning her research into patentable therapies or commercial applications would increase its societal and economic impact.

  2. Leadership Roles:
    While active in research, taking on editorial or scientific leadership positions would enhance her academic visibility and influence.

  3. Internationalization:
    She would benefit from developing international collaborations or fellowships to diversify her research scope and increase global reach.

  4. Industry Engagement:
    Engaging in consultancy or biotech partnerships can further the translational impact of her regenerative strategies.

🎓 Education:

Dr. Takejima’s educational journey began with a Doctor of Medicine (MD) degree from the Pontifical Catholic University of Paraná (PUCPR), Brazil. Her passion for research led her to pursue a Doctorate (PhD) in Health Sciences/Medicine, also at PUCPR. Her doctoral thesis focused on the use of biologically active materials such as the amniotic membrane and stem cells to enhance wound healing. Throughout her academic training, she demonstrated a strong commitment to translational medicine by integrating basic science with clinical practice. During her PhD, she engaged in experimental models involving stem cell therapy and tissue engineering, which laid the groundwork for her current postdoctoral research. Her educational path reflects both depth and specialization in the biomedical sciences, particularly in regenerative medicine and cellular therapies.

💼 Experience:

Dr. Aline Takejima has over a decade of experience in medical and scientific fields, balancing her role as a physician with that of a postdoctoral researcher. Her clinical background informs her research, particularly in areas of wound healing and regenerative medicine. At PUCPR, she contributes to the Wound Healing Research Group, where she is involved in designing and conducting animal model studies to test the effects of biomaterials and stem cells. Her multidisciplinary research integrates immunology, histopathology, and molecular biology. With nine peer-reviewed publications and participation in collaborative research, she has become a respected contributor to the field. Though early in her research career, her trajectory shows a steady rise, marked by evidence-based outcomes and a commitment to innovation. Her goal is to bridge clinical challenges with regenerative solutions that can be implemented in real-world medical practice.

🔬 Research Focus:

Dr. Takejima’s research focuses on regenerative strategies for wound healing, utilizing biomaterials and stem cells. Her work primarily explores the application of amniotic membrane, Wharton’s jelly, and bone marrow-derived mononuclear stem cells in treating complex or chronic skin wounds. Using experimental models in rats and rabbits, she evaluates histological recovery, inflammation modulation, and tissue regeneration. A significant aspect of her research is understanding how these materials promote healing through paracrine effects rather than direct integration, offering a safer and scalable pathway to clinical application. Additionally, her work extends to cardiac and tracheal tissue repair, emphasizing the versatility of these regenerative approaches. The translational nature of her research bridges laboratory discoveries with potential bedside applications, positioning her at the forefront of cellular therapy and biomaterials science.

📚 Publications Top Notes:

  1. 🧠 Wharton’s Jelly Bioscaffolds Improve Cardiac Repair with Bone Marrow Mononuclear Stem Cells in Rats – Journal of Functional Biomaterials, 2025

  2. 🧫 The effects of decellularized amniotic membrane and Wharton’s jelly on the healing of experimental skin wounds in rats – Tissue Barriers, 2025

  3. ❤️ Bone-marrow mononuclear cells and acellular human amniotic membrane improve global cardiac function… – Anais da Academia Brasileira de Ciências, 2024

  4. 🫁 Tracheal regeneration with acellular human amniotic membrane and 15d-PGJ2 nanoparticles in rabbits – Anais da Academia Brasileira de Ciências, 2023

  5. 🧬 Acellular Biomaterials + Autologous Stem Cells Improve Wound Healing via Paracrine Effects – Biomedicines, 2023

  6. 💉 Decellularized Amniotic Membrane Solubilized with Hyaluronic Acid in Wound Healing – Annals of Biomedical Engineering, 2022

  7. 🧪 Role of Mononuclear Stem Cells and Decellularized Amniotic Membrane in Skin Wounds – Tissue Barriers, 2022

  8. 🏥 Trauma hepático: epidemiologia de cinco anos… – Revista do Colégio Brasileiro de Cirurgiões, 2008

🧾 Conclusion:

Dr. Aline Luri Takejima is an outstanding candidate for the Women Researcher Award. Her academic profile demonstrates a strong foundation in regenerative medicine with significant contributions to wound healing research. Her commitment to applying biological therapies in clinical contexts shows both depth and innovation. As a woman scientist in a competitive field, she exemplifies leadership, dedication, and potential. With further growth in global engagement and innovation strategy, Dr. Takejima is poised to become a future leader in regenerative biomedical research.

Alaka Sahoo | Immunology Cellular Interactions | Young Researcher Award

Published on by Cell Biologist

Mrs. Alaka Sahoo | Immunology Cellular Interactions | Young Researcher Award

Mrs. Alaka Sahoo, Siksha’O’ Anusandhan University, India

Dr. Alaka Sahoo is a dedicated young researcher in the field of Biotechnology with a focus on translational and clinical research. She holds a Ph.D. in Biotechnology from Siksha ‘O’ Anusandhan University, Odisha, with a CGPA of 8.90. With over 17 publications, including 11 research articles and 3 high-impact reviews, Dr. Sahoo has significantly contributed to oral disease therapeutics and antimicrobial studies. She demonstrates expertise in multi-omics analysis, drug discovery, and natural product-based therapy. A recipient of prestigious awards such as the Lalchand Women Entrepreneurs Award (2024), she is also a life member of reputed organizations like the British Society for Antimicrobial Chemotherapy. Her innovative approach to disease management using phytochemicals and peptides sets her apart as a rising talent in biomedical research.

Publication Profile: 

Google Scholar

Scopus

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record:

    • 17 publications including 11 original research, 3 reviews, and 2 book chapters, showcasing depth and breadth.

    • 7 papers as first or corresponding author—indicating independent research capability.

    • Research in high-impact journals like Frontiers in Microbiology, Journal of Ethnopharmacology, Nanomaterials, and Chemistry & Biodiversity.

  2. Innovative & Multidisciplinary Research:

    • Integrates multi-omics, computational modeling, clinical dermatology, and natural products.

    • Focus on oral inflammatory diseases, antimicrobial peptides, and drug delivery systems.

  3. Academic Excellence & Research Training:

    • Ph.D. with 8.90 CGPA, and M.Sc. with 87.07% marks.

    • Expertise in BSL-2+ lab work, PCR, ELISA, microbial culture, and molecular docking.

  4. Awards & Recognition:

    • Lalchand Women Entrepreneurs Award (2024).

    • MSME-Idea Hackathon Innovation Award, Govt. of India.

  5. Global and National Engagement:

    • Life member of the British Society for Antimicrobial Chemotherapy (UK).

    • Demonstrates leadership in science entrepreneurship and women in research.

🛠️ Areas for Improvement:

  1. Expanded International Collaboration:

    • Building long-term research partnerships with international labs could increase global visibility.

  2. Patent/Technology Transfer Efforts:

    • While publications are strong, translating research into patents or commercial products will further strengthen applied impact.

  3. Focused Project Leadership:

    • Leading large interdisciplinary projects or acquiring independent grants will showcase funding leadership.

🎓 Education:

Dr. Alaka Sahoo has pursued a progressive academic path in Biotechnology. She earned her Ph.D. in Biotechnology from the School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan Deemed University, Odisha, completing her research with a notable 8.90 CGPA. Her thesis focused on “Therapeutic Opportunities for Oral Lichen Planus: An Integrated Multi-Omics Approach to Drug Discovery” under the guidance of Prof. (Dr.) Maitreyee Panda. Prior to this, she completed her M.Sc. in Biotechnology (87.07%) from the College of Basic Science and Humanities, OUAT, Bhubaneswar in 2018 and a B.Sc. in Biotechnology with distinction (75%) from Ramadevi Women’s College, Utkal University in 2016. Her academic journey showcases a strong foundation in both theoretical and applied aspects of biosciences.

💼 Experience:

Dr. Alaka Sahoo brings rich hands-on research experience in clinical and experimental biotechnology. She is skilled in BSL-2+ lab practices, molecular techniques like PCR, gel electrophoresis, microbial culture, ELISA-based diagnostics, and bioinformatics. Her doctoral work integrated multi-omics and computational biology to study inflammatory oral diseases, and her postdoctoral research spans drug delivery and antimicrobial drug discovery. As first or corresponding author in 7 out of 17 publications, she has led collaborative studies with both national and international partners. Dr. Sahoo’s cross-disciplinary knowledge in microbiology, pharmacology, and nanomedicine enhances her problem-solving abilities, making her a versatile researcher. Her ability to bridge clinical dermatology with biotechnology research positions her as an impactful contributor in both healthcare and academic environments.

🏆 Awards & Honors:

Dr. Alaka Sahoo has received notable accolades for her innovation and leadership in science. In 2024, she was awarded the Lalchand Women Entrepreneurs Award by the Odisha Corporate Foundation, recognizing her outstanding contributions in biotech innovation. She also earned the MSME-Idea Hackathon 3.0 (Women) Innovation Award by the Government of India, honoring her practical scientific advancements with societal impact. These awards reflect her dedication to translational research and her vision to develop cost-effective, natural therapies. Dr. Sahoo is also a life member of two esteemed organizations: the British Society for Antimicrobial Chemotherapy (UK) and Bioclues Innovation, Research and Development (India). Her achievements signify her rising prominence in the field and her commitment to addressing public health challenges through integrative research.

🔬 Research Focus:

Dr. Alaka Sahoo’s research focuses on oral inflammatory diseases, natural product therapeutics, and insect-derived peptides as alternatives to conventional antimicrobials. Her Ph.D. thesis explored multi-omics approaches for drug discovery in Oral Lichen Planus, integrating in vitro, in silico, and clinical data. Her work spans immunomodulation, anti-inflammatory drug screening, and nanodrug delivery systems, with cross-functional expertise in dermatology, pharmacology, and microbiology. She combines computational modeling, molecular docking, and wet-lab validation to develop target-specific therapies. Her studies on biofilm inhibition, antifungal peptides, and phytosteroids hold promise for tackling antimicrobial resistance. Through collaborations across academia and healthcare, she aims to translate her lab findings into clinically viable solutions. Her contributions to systematic reviews and molecular simulations further demonstrate her analytical rigor and commitment to evidence-based research.

📚 Publications Top Notes:

  1. 📘 Experimental and clinical trial investigations of phytoextracts in Oral Lichen Planus: A systematic review – J Ethnopharmacol (2022)

  2. 🐞 Insect-derived antimicrobial peptides as novel anti-biofilm agents: A systematic review – Front. Microbiol. (2021)

  3. 💊 Ultraflexible liposome nanocargo for dermal drug delivery – Nanomaterials (2021)

  4. 🌿 Phytochemicals for Oral Lichen Planus: A multi-omics and experimental study – Chem Biodivers (2025)

  5. ⚗️ Carbohydrate-derived N-benzyl aminocyclopentitols with anticancer properties – Carbohydr Res. (2025)

  6. 🧬 Target-specific screening of anti-inflammatory phytosteroids using molecular docking – Steroids (2025)

  7. 🧪 Insect-derived antifungal peptides in Candida management – Int. J. Mol. Sci. (2025)

  8. 🧫 Azo-coumarin-Co(II)-galangin hybrids for multipotential activities – J. Biomol. Struct. Dyn. (2024)

  9. 🧒 Pediatric dermatology case analysis in Eastern India – Indian J. Paediatr. Dermatol. (2024)

  10. 🔬 Schiff/Mannich coumarin derivatives: Antibacterial and anti-biofilm evaluation – RSC Adv. (2024)

🧾 Conclusion:

Dr. Alaka Sahoo is highly suitable for the Research for Young Researcher Award. Her multi-disciplinary expertise, robust research record, and recognition through national awards highlight her as a promising early-career scientist. She combines academic rigor with innovation, and her work has meaningful implications for public health, especially in oral disease therapy, biofilm inhibition, and phytochemical-based drug development.

Song He | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Dr. Song He | Tissue Engineering Regeneration | Best Researcher Award

Dr. Song He, Hunan University of Humanities, Science and Technology, China

Dr. Song He is a dedicated researcher and lecturer at the School of Energy and Mechanical Engineering, Hunan University of Humanities, Science and Technology. With a strong background in civil materials and energy systems, Dr. He has made impactful contributions in the field of nanoporous aluminum substrates, heat transfer mechanisms, and condensation processes. His research bridges fundamental science and engineering applications, particularly in energy efficiency and materials performance. As a first author on multiple high-impact publications and an inventor on several patents, he has demonstrated both technical depth and innovation. Dr. He’s work is recognized for addressing real-world challenges in sustainable cooling and energy systems. His career path reflects consistent academic growth from undergraduate studies through to a PhD, followed by impactful research and teaching contributions. Passionate about material science and thermal dynamics, Dr. He exemplifies the qualities of a next-generation scientific leader.

Publication  Profile:

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record (First Author & Peer-Reviewed)

    • Multiple first-author journal articles in internationally recognized journals like Materials, Applied Sciences, Energies, and Journal of Materials Research and Technology.

    • Research is focused on high-impact, emerging areas like nanoporous aluminum substrates, solar thermal applications, and frosting mechanisms.

  2. Innovation and Practical Contribution

    • Holder of three patents related to testing devices for heat transfer and solar radiation absorption of aluminum materials, showing real-world application of research.

  3. Specialization in Sustainability and Energy Efficiency

    • Research closely aligns with modern needs for sustainable cities, renewable energy, and climate-adaptive cooling technologies.

    • Topics such as interface condensation, solar absorption, and surface coatings are directly relevant to global energy challenges.

  4. Long-Term Academic and Research Dedication

    • Strong academic background (BEng + PhD) and a consistent career trajectory.

    • Lecturer since 2020, actively involved in both teaching and applied research.

🔧 Areas for Improvement:

  1. Broader International Engagement Needed

    • Limited visibility in international conferences, workshops, and global collaborative projects.

    • Increasing participation in international academic communities would enhance both recognition and impact.

  2. Publication Impact and Journal Tier

    • While the journals are respectable, publishing in top-tier (Q1) journals like Advanced Materials, Nano Energy, or Energy & Environmental Science could elevate the scientific profile.

  3. Postdoctoral or International Fellowships

    • No postdoctoral experience or overseas academic training mentioned.

    • Pursuing a global postdoctoral opportunity would enhance expertise and network.

🎓 Education:

Dr. Song He holds a Ph.D. in Civil Materials and Engineering from Guangdong University of Technology (2015–2020), where his research focused on advanced thermal interface materials and nanoporous substrates. Prior to this, he completed his Bachelor’s degree in Building Environment and Equipment Engineering at Hunan University of Technology (2011–2015), laying the foundation for his interest in energy systems and materials performance. His academic training included interdisciplinary exposure to heat exchange technologies, solar energy applications, and environmental materials, combining theory with hands-on experimentation. Through his doctoral studies, Dr. He developed expertise in micro/nanoporous materials, surface treatments, and condensation properties critical to energy efficiency systems. His strong academic record and progression reflect his commitment to high-impact research and continuous learning. Dr. He’s educational background has prepared him to lead and innovate in the domains of thermal sciences, sustainable technologies, and energy-efficient materials.

💼 Experience:

Since December 2020, Dr. Song He has been a lecturer at the School of Energy and Mechanical Engineering, Hunan University of Humanities, Science and Technology. His teaching and research focus on material science, energy engineering, and surface phenomena. Prior to this, he completed his Ph.D. at Guangdong University of Technology, where he was actively involved in national and regional research projects. Dr. He has collaborated with notable researchers, contributed to interdisciplinary research teams, and co-authored several scientific papers. His hands-on experience includes the development and testing of novel nanoporous aluminum sheets for thermal applications. He has also contributed to the design and patenting of specialized testing devices for thermal and frosting properties. With a blend of academic and experimental work, Dr. He has developed deep knowledge in sustainable materials and surface engineering. His career showcases a balance of scientific inquiry, practical innovation, and educational contribution.

🔬 Research Focus:

Dr. Song He’s research centers on the thermal and surface properties of nanoporous aluminum materials and their applications in energy-efficient systems. His work explores the interface effects, condensation characteristics, solar absorption, and frosting mechanisms of micro/nanostructured materials. A significant part of his research focuses on improving heat exchanger efficiency, air-conditioning performance, and solar thermal energy capture through material innovation. He has studied the role of hygroscopic coatings and nanoporous substrates in enhancing thermal transfer and minimizing frost formation. Dr. He also investigates material-environment interactions, including moisture absorption and radiation management, to support sustainable building technologies. His patented devices offer novel methods for testing aluminum sheets under various environmental conditions. His work bridges fundamental surface physics with real-world energy applications, addressing critical needs in sustainable cities, green energy systems, and advanced thermal technologies. His focus positions him at the intersection of materials innovation and energy efficiency.

📚 Publications Top Notes:

  1. 📘 Investigation of the Interface Characteristics and Frosting Properties of the Nanoporous Alumina Sheets – Journal of Materials Research and Technology, 2025

  2. 🔬 Review of Hygroscopic Coating on Aluminum Fin Surface of Air Conditioning Heat Exchanger – Applied Sciences, 2021

  3. 🌞 Investigation on the Solar Absorption Property of the Nanoporous Alumina Sheet for Solar Application – Materials, 2019

  4. ❄️ Effects and Frosting Mechanism of Nanoporous Alumina Sheets – Energies, 2023

  5. 🧪 Investigation of the Interface Effects and Condensation Properties of the Micro/Nanoporous Aluminum Plates – Sustainable Cities and Society, (Date unspecified)

📌 Conclusion:

Dr. Song He is a highly promising candidate for the Best Researcher Award, especially for his contributions to nanomaterials, surface engineering, and sustainable energy applications. He brings a combination of academic rigor, innovation, and application-driven research that addresses critical energy and environmental challenges.

Wei Zhang | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Wei Zhang | Signal Transduction Mechanisms | Best Researcher Award

Prof. Dr. Wei Zhang | Central South University | China

Dr. Wei Zhang, born on December 29, 1977, is a leading expert in clinical pharmacology and pharmacogenomics at the Institute of Clinical Pharmacology, Central South University, China. With over two decades of dedication to personalized medicine and drug-gene interaction research, Dr. Zhang has advanced the fields of pharmacokinetics, pharmacodynamics, and gut microbiome-pharmacology interactions. His global experience includes a research stint at the University of Maryland, USA. As a professor, scientific secretary, and associate dean, he contributes significantly to clinical research, translational pharmacogenomics, and academic leadership. Dr. Zhang has led multiple national research grants and published in top-tier journals like The Lancet, Nature Communications, and Signal Transduction and Targeted Therapy. His research bridges clinical pharmacology and precision medicine, with a particular focus on diabetes, cancer immunotherapy, and microbiome-drug interactions.

Publication profile:

Scopus

✅ Strengths for the Award:

  1. Outstanding Research Leadership
    Dr. Wei Zhang has served as a principal investigator for over 7 nationally funded projects, including China’s prestigious 863 Program and multiple NSFC grants. These projects span pharmacogenomics, clinical pharmacology, and personalized medicine, highlighting his leadership in cutting-edge translational research.

  2. Pioneering Work in Pharmacogenomics & Microbiome
    He has contributed significantly to the drug-gene-microbiota interaction field, especially in type 2 diabetes, cancer immunotherapy, and nephrotoxicity. His discoveries on SLCO1B1, TRIB3, OATP1B1, and CYP2A6 variations have direct implications for individualized therapy.

  3. Global Research Recognition
    His work is published in high-impact journals such as The Lancet, Nature Communications, Signal Transduction and Targeted Therapy, and Advanced Science. These publications attest to both quality and international relevance.

  4. Interdisciplinary Innovation
    Dr. Zhang bridges clinical pharmacology, bioinformatics, and microbial science, addressing unmet needs in precision medicine. His focus on gut microbiota’s role in drug efficacy and toxicity represents a visionary, interdisciplinary approach.

  5. Academic Mentorship & Leadership
    He has held senior academic roles (Professor, Associate Dean, Scientific Secretary), contributing to the development of academic programs and mentoring the next generation of clinical pharmacologists.

  6. Award-Winning Profile
    With over 9 prestigious national awards, including the New Century Talent Award, Henry Fok Young Teacher Award, and honors from the Chinese Ministry of Education, his contributions are officially recognized at the national level.

⚠️ Areas for Improvement:

  1. International Collaboration Expansion
    While Dr. Zhang has completed a visiting scholar stint in the U.S., expanding ongoing multi-national clinical collaborations (e.g., with EU or U.S. precision medicine centers) would further globalize his impact.

  2. Public Communication & Outreach
    His work is academically impactful but could benefit from greater visibility in public health or policymaking arenas, translating research findings into clinical guidelines or patient-accessible formats.

  3. Patents & Industry Translation
    While his academic output is prolific, increased technology transfer—e.g., pharmacogenetic diagnostics or drug screening tools—would further boost his profile as a translational scientist.

🎓 Education:

Dr. Wei Zhang obtained his entire academic education from Central South University in Changsha, Hunan, China. He earned his Ph.D. in Pharmacology (2003–2006) under the mentorship of Professor Hong-Hao Zhou, a member of the China Engineering Academy. His doctoral work centered on clinical pharmacology, with strong emphasis on drug assays and clinical trials. Prior to this, he received his M.A. in Pharmacology (2001–2003), focusing on pharmacogenomics and drug metabolism, gaining hands-on expertise in pyrosequencing and human DNA analysis. Dr. Zhang began his academic journey with a B.A. in Clinical Medicine (1996–2001) from XiangYa Medical School, where he built a solid foundation in pharmacology, physiology, and clinical medicine. This comprehensive academic trajectory laid the groundwork for his research in personalized therapy, pharmacogenetics, and pharmacokinetics, making him a key contributor in China’s pharmacological landscape.

🧪 Experience:

Dr. Wei Zhang currently serves as Professor at the Department of Clinical Pharmacology, Central South University, since 2013. Since 2009, he has also held the post of Associate Dean at the Institute of Clinical Pharmacology. Previously, he was an Associate Professor (2008–2013), Head of the Genetic Testing Laboratory (2007–2013), and Lecturer (2006–2008). He also contributes administratively as the Scientific Secretary of the National Key Discipline of Pharmacology since 2005. Dr. Zhang gained international experience as a Visiting Scholar at the University of Maryland, USA (2012–2013), further broadening his research expertise. Throughout his career, he has played a pivotal role in pharmacogenomic translation, clinical trials, and precision medicine development, mentoring students and managing large research teams. His leadership and administrative skills have contributed to elevating China’s presence in global pharmacology research.

🏅 Awards and Honors:

Dr. Wei Zhang’s distinguished career has been recognized with numerous prestigious awards. As a student, he received the “Class I Scholarship” and “Outstanding Postgraduate Student” awards in 2004 and 2005, followed by the “Excellent Report Award” from the Chinese Pharmacological Society in 2005. In 2006, he was named an Outstanding Graduate by Central South University. His research excellence earned him the “New Century Excellent Talents” award from the Chinese Ministry of Education in 2010 and the Science and Technology Prize of the Chinese Society of Pharmacy. He received international recognition in 2012 with a foreign fund from the China Scholarship Council. He was also honored as an “Outstanding Young Talent” by the Organization Department of China in 2013, and in 2014 received the esteemed “Henry Fok Young Teacher Award.” These accolades underscore his influential contributions to pharmacogenomics and clinical research in China.

🔬 Research Focus:

Dr. Wei Zhang’s research is centered around clinical pharmacology, pharmacogenomics, and drug-microbiome interactions, with a mission to enable personalized medicine. His work investigates the genetic and microbial determinants of drug efficacy, toxicity, and metabolism, especially in type 2 diabetes, cancer immunotherapy, and nephrotoxic drugs like cisplatin. He has led major national projects funded by the National Natural Science Foundation of China and the 863 Program, exploring the pharmacogenomic landscape and the gut microbiota’s impact on drug response. Dr. Zhang’s translational focus bridges laboratory findings to clinical application, utilizing genomic tools and bioinformatics to optimize therapy. His innovative research has unveiled how bacterial metabolites and transporters influence drug absorption and immune modulation, contributing significantly to the understanding of precision pharmacology. Through interdisciplinary collaborations, his work pushes boundaries in oncology, endocrinology, and microbiome science.

📚 Publications Top Notes:

  1. 🧬 SLCO1B1 variants and enalapril-induced cough – The Lancet (2015)

  2. 💉 TRIB3 Gln84Arg and vascular complications in T2DM – Lancet Diabetes & Endocrinology (2016)

  3. 🧠 Pharmacogenomics of hERG potassium channels – Trends in Molecular Medicine (2013)

  4. 🌱 Eubacterium rectale enhances anti-PD1 immunotherapy – Research (2023)

  5. 💊 Bacteroides ovatus and metformin-induced B12 deficiency – NPJ Biofilms Microbiomes (2023)

  6. 🧨 Cancer nanobombs enhancing PD-L1 expression – Advanced Science (2024)

  7. 🌿 Regulatory effects of herbal compounds on gut bacteria – Pharmacological Research (2023)

  8. 🔄 Drug–microbiota interactions in precision medicine – Signal Transduction and Targeted Therapy (2023)

  9. 🧫 Microbiota variation and ICI response – Nature Communications (2023)

  10. 🔬 Peptides from Sutterella potentiate PD-1 blockade – Gut (2024)

🧾 Conclusion:

✅ Recommendation: Highly Suitable for Best Researcher Award

Dr. Wei Zhang exemplifies the ideal candidate for the Best Researcher Award. His robust scientific portfolio, pioneering work in pharmacogenomics and drug–microbiota interaction, along with his leadership in both academia and national projects, demonstrate excellence, innovation, and long-term impact. While further expansion into international policy or industry translation could enhance his reach, his current achievements already position him at the forefront of clinical pharmacology and personalized medicine in China and globally.

qingwei lu | Cell Differentiation Processes | Innovative Research Award

Published on by Cell Biologist

Mr. qingwei lu | Cell Differentiation Processes | Innovative Research Award

Mr. qingwei lu , Xinjiang Academy of Animal Sciences , China

Qingwei Lu is a student at the Xinjiang Academy of Animal Sciences, China, specializing in animal genetics, breeding, and reproduction. His research focuses on the genetic improvement of wool and meat sheep, specifically through quantitative genetics, population genetic analysis, and genomic selection for key traits. Qingwei also explores the molecular mechanisms behind hair follicle development in cashmere goats, applying transcriptomics and proteomics to understand hair follicle cycling and its relationship with production traits. His studies aim to provide scientific foundations for breeding and industrial development in the livestock sector. Qingwei is actively involved in national and international research collaborations and has published multiple academic papers in prominent journals. His work contributes significantly to the field of animal genetics and breeding, making him a promising researcher with a growing impact in the industry.

Publication Profile:

Orcid

Strengths for the Award:

Qingwei Lu’s work demonstrates remarkable innovation in the field of animal genetics, with a particular emphasis on sheep and cashmere goats. His integration of transcriptomics and proteomics techniques to study the genetic and molecular mechanisms of hair follicle development, especially in cashmere goats, is groundbreaking. The focus on secondary hair follicle cycling and the role of PLIN2 in regulating this cycle offers important insights for enhancing wool and meat production traits. Furthermore, his research is supported by substantial funding, such as the National Key R&D Program and the National Natural Science Foundation of China, underlining the relevance and impact of his work. His numerous published journal articles, including in high-impact journals, also reflect his contributions to advancing the scientific understanding of animal breeding and genetics.

Areas for Improvements:

While Qingwei Lu’s research is highly innovative and impactful, expanding his collaborative network further to include industry partners could enhance the translational aspect of his research. Additionally, more engagement with public-facing scientific communication and outreach could make his discoveries more accessible to a broader audience, including agricultural industries and farmers.

Education:

Qingwei Lu is currently pursuing advanced studies at the Xinjiang Academy of Animal Sciences in China. He holds a bachelor’s degree in animal science, followed by graduate studies focused on animal genetics and breeding. His academic journey is heavily centered on animal genetics, specifically in the context of wool and meat sheep, as well as the genetic improvement of cashmere goats. Qingwei’s research includes the application of quantitative genetics, genomic selection, and molecular techniques to unravel complex genetic traits in livestock. His education equips him with strong foundations in both the theoretical and practical aspects of animal breeding, enabling him to work effectively on high-impact national research projects. Qingwei’s academic achievements reflect his dedication to the scientific advancement of animal science, particularly in genetic evaluation and breeding program optimization.

Experience:

Qingwei Lu’s research experience spans multiple projects in the field of animal genetics and breeding. His primary research focuses on the genetic enhancement of sheep and goats, particularly wool and meat sheep, and cashmere goats, through innovative approaches in genomics and molecular biology. Qingwei’s work includes estimating genetic parameters, analyzing population genetic structures, and implementing genomic selection to improve economic traits in livestock. He is currently involved in key national research programs in China, including the National Key R&D Program (2021YFD1200902) and the National Natural Science Foundation of China Regional Science Fund (32360814). His collaborative research efforts have resulted in numerous journal publications. Qingwei also collaborates on industry-sponsored projects, contributing his expertise to practical breeding solutions for livestock farmers. His expertise in combining transcriptomics, proteomics, and genomic techniques is making a significant impact on livestock breeding and industrial development.

Research Focus:

Qingwei Lu’s research focus revolves around the genetic improvement of livestock, with particular emphasis on wool and meat sheep, and cashmere goats. His research involves the use of quantitative genetics to estimate genetic parameters, analyze population genetic structures, and implement genomic selection for important economic traits such as early growth and reproductive traits. Additionally, Qingwei studies the genetic and molecular mechanisms of hair follicle development in cashmere goats, aiming to uncover the regulatory pathways behind hair follicle cycling. His work integrates transcriptomics, proteomics, and genomic sequencing techniques to explore how these molecular processes influence the production of wool and cashmere. By understanding these molecular mechanisms, Qingwei seeks to develop breeding strategies that can enhance productivity and economic outcomes in the livestock industry. His work provides valuable insights for improving livestock breeding programs and contributes to the scientific foundation for the development of more sustainable and profitable animal farming.

Publications Top Notes:

  1. Screening of CircRNA Related to Secondary Hair Follicle Cycling in Southern Xinjiang Cashmere Goats
    🐐📚 Chinese Journal of Animal Husbandry and Veterinary Medicine, 2024 | DOI: 10.19556/j.0258-7033.20230117-04

  2. Effects of Non-genetic Factors on Early Growth Traits in Southern Xinjiang Cashmere Goats
    🐐📖 Chinese Journal of Animal Science, 2024 | DOI: 10.16431/j.cnki.1671-7236.2024.05.001

  3. Research on the Cyclical Patterns of Different Types of Hair Follicles in Southern Xinjiang Cashmere Goats
    🐐🔬 Chinese Journal of Animal Science, 2025 | DOI: 10.19556/j.0258-7033.20240422-10

  4. Comparison of Different Animal Models for Estimating Genetic Parameters for Early Growth Traits and Reproductive Traits in Tianmu Sainuo Sheep
    🐑📄 Frontiers in Veterinary Science, 2024 | DOI: 10.3389/fvets.2024

  5. Proteomics Reveals the Role of PLIN2 in Regulating the Secondary Hair Follicle Cycle in Cashmere Goats
    🧬🐐 International Journal of Molecular Sciences, 2025 | DOI: 10.3390/ijms26062710

Conclusion:

Qingwei Lu’s innovative approach to genetic improvement in sheep and goats, particularly his exploration of hair follicle regulation mechanisms and their relation to production traits, makes him an excellent candidate for the Innovative Research Award. His contributions to advancing genetic evaluation and breeding programs have the potential to greatly impact agricultural industries, aligning well with the goals of the award.

Mohamed Sadek BACHENE | Microbial Cell Biology | Best Innovation Award

Published on by Cell Biologist

Assoc. Prof. Dr. Mohamed Sadek BACHENE | Microbial Cell Biology | Best Innovation Award

Assoc. Prof. Dr. Mohamed Sadek BACHENE , Institute of Veterinary Sciences at the University of Médéa , Algeria

Dr. Mohamed Sadek Bachene is a distinguished veterinarian and academic from Algeria, born on November 26, 1984, in Medea. He holds extensive experience in veterinary medicine, academic teaching, and scientific research. Bachene has contributed to numerous scientific publications and has presented at international conferences. He is a recognized educator and supervisor in the field of veterinary science, particularly in histology, animal physiology, and pathology. With a strong background in veterinary sciences, Bachene has made significant contributions to the study of coccidiosis in rabbits and broiler chickens. He is highly active in the development of veterinary education and scientific research in Algeria, earning recognition for his innovation and academic leadership.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Mohamed Sadek Bachene’s work stands out for its deep focus on veterinary parasitology, particularly in combating coccidiosis in rabbits and broiler chickens. His innovative research on vaccine trials for Eimeria magna and other parasites in Algerian local rabbits has made significant strides in the prevention of coccidiosis. His published studies and presentations at international conferences highlight the practical applications of his work in veterinary medicine, especially in local farming contexts. Bachene’s ability to combine academic teaching, research, and practical veterinary practice demonstrates a holistic approach that benefits both the academic and professional veterinary communities.

Areas for Improvement:

While Dr. Bachene has made substantial contributions, there is potential for growth in collaborative, interdisciplinary research. Engaging in more international partnerships or joining larger research consortia could increase the scope of his work. Additionally, a greater emphasis on the long-term environmental and socio-economic impacts of his research in rural areas could further strengthen the relevance of his work to both the veterinary and agricultural industries.

Education:

Dr. Mohamed Sadek Bachene holds a Ph.D. in Veterinary Sciences (2013–2019) from ENSV and a Magister degree (2009–2013) in Veterinary Sciences with a specialization in breeding and pathology of backyard animals. His academic journey is complemented by short-term internships at Beijing Agricultural University, focusing on PCR and sequencing of parasite genetic material. Additionally, Bachene completed a university accreditation in Veterinary Sciences (2019–2021). He has excelled in both research and practical application, contributing to significant advancements in the study of animal health and pathology.

Experience:

Dr. Bachene’s professional experience spans from private veterinary practice in 2011 to prominent academic roles, including teaching at Blida and Médéa Universities. He has served as a Teacher-Assistant at YAHIA FARES Médéa University and held a leadership position as Co-head of the Department responsible for graduation and pedagogy (2016–2019). In addition, he actively participated in university governance through memberships in administrative councils and scientific commissions. His administrative and academic leadership roles have shaped veterinary education and research within the university system.

Research Focus:

Dr. Bachene’s research is focused on veterinary parasitology, with a particular interest in coccidiosis in rabbits and poultry. He has conducted extensive studies on Eimeria species, exploring their pathogenicity, prevalence, and potential vaccination strategies. His work in the field of veterinary medicine includes the development of experimental vaccines and the study of parasite genetics using molecular techniques. Bachene’s research aims to improve animal health management practices, specifically in rural and agricultural settings, and to contribute to the overall betterment of veterinary care in Algeria.

Publications Top Notes:

  • 2018: “A vaccination trial with a precocious line of Eimeria magna in Algerian local rabbits” 🐇💉
  • 2018: “Prevalence of coccidian infection in rabbit farms in North Algeria” 🐇🔬
  • 2019: “Prevalence of Rabbit Coccidia in Medea Province, Algeria” 🐇📊
  • 2021: “Vaccination of Algerian Local Rabbits with Precocious Strains of Eimeria magna and Eimeria media” 🐇💉
  • 2025: “Prevalence of coccidiosis in broiler chickens in Medea, Algeria” 🐔🔬

Conclusion:

Dr. Mohamed Sadek Bachene is highly deserving of the Research for Best Innovation Award due to his exceptional work in veterinary parasitology, his innovation in vaccine development, and his commitment to improving animal health and farming practices in Algeria. His active role in education, research, and professional development in veterinary science makes him an outstanding candidate. Enhancing global collaborations and focusing on sustainable, long-term impact could further amplify the influence of his research.